Glucose-Na-K Baxter (Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Glucose, Sodium Acetate Trihydr)

Glucose-Na-K Baxter is indicated for several clinical situations where fluid, electrolyte, and energy replacement are required.

• Rehydration and maintenance of fluid balance in patients with dehydration or ongoing losses.
• Correction of electrolyte disturbances, including low potassium, sodium, or magnesium levels.
• Provision of glucose for patients at risk of hypoglycemia or requiring caloric support during fasting.
• Post‑operative or post‑procedural hydration to support recovery after surgery.
• Adjunct therapy in metabolic disorders where acetate serves as a buffer for acid‑base balance.

The safety profile of Glucose-Na-K Baxter reflects the components of the solution; most patients experience mild, transient effects, while rare serious reactions may occur.

Common

• Mild irritation at the infusion site, such as redness or discomfort.
• Transient increase in blood glucose levels.
• Mild electrolyte shifts causing temporary nausea or headache.
• Low-grade fever related to infusion.

Serious

• Severe hyperkalemia leading to cardiac arrhythmias.
• Anaphylactic or severe allergic reaction to any component.
• Rapid fluid overload causing pulmonary edema.

When prescribing Glucose-Na-K Baxter, clinicians should evaluate patient-specific factors and monitor for potential complications.

• Assess baseline electrolyte levels and renal function before initiating therapy.
• Use caution in patients with congestive heart failure or pulmonary edema due to risk of fluid overload.
• Avoid rapid infusion rates that may cause sudden shifts in potassium or magnesium.
• Monitor blood glucose closely in diabetic patients or those receiving other glucose-containing solutions.
• Consider the acetate content in patients with severe metabolic acidosis.
• Pregnancy and lactation status should be reviewed, as safety data are limited.
• Store the solution according to manufacturer guidelines to maintain sterility.

Glucose-Na-K Baxter may interact with other medications that affect electrolyte balance, glucose metabolism, or fluid status.

Avoid

• Concurrent use of potassium‑sparing diuretics or high‑dose potassium supplements, which can precipitate hyperkalemia.
• Co‑administration with magnesium‑containing antacids or supplements that may cause excessive magnesium levels.
• Combination with sodium bicarbonate solutions, which may increase sodium load and affect acid‑base status.

Use with caution

• Intravenous insulin therapy, which can lower blood glucose and shift potassium intracellularly.
• Loop diuretics or other agents that promote electrolyte loss, requiring closer monitoring.
• Blood transfusions or large-volume crystalloid infusions that may alter fluid balance.
• Administration with vasopressors, as changes in vascular tone can modify fluid distribution.
• Vasopressor agents may require adjusted infusion rates to maintain hemodynamic stability.